Ledger.Open graph →
SEC Form D · filed August 25, 2015

Checkmate Pharmaceuticals, Inc

Offering
$20.0M
Sold
$10.0M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
CAMBRIDGE, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

Corey A. Goodman · Cambridge, MADirectorArthur A. Krieg · Cambridge, MAExec · DirectorChuck A. Abdalian · Cambridge, MAExecMichael A. Powell · Cambridge, MADirectorRandall H. Guthrie · Colorado Springs, COExecJohn A. Gloriod · Colorado Springs, CODirectorJean A. Pineault · Colorado Springs, CODirectorArthur A. Krieg · Cambridge, MAExec · DirectorBryan Frisina · ALISO VIEJO, CAExec · DirectorDean P. Stull · Colorado Springs, COExecMichael K. Germino · New York, NYDirectorScott K. Bessent · New York, NYDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗